TIGIT and non-small cell lung carcinoma: Indeed, TIGIT was found to be expressed on the lymphoid cells in non-small cell lung carcinoma (NSCLC), melanoma, breast cancer, colon adenocarcinoma (COAD), AML, and multiple myeloma (MM)4,29–32.